Literature DB >> 1383835

CP-96,345, a non-peptide antagonist of substance P: II. Actions on substance P-induced hypotension and bronchoconstriction, and on depressor reflexes in mammals.

T Griesbacher1, J Donnerer, F J Legat, F Lembeck.   

Abstract

In order to extend the in vivo pharmacological profile of CP-96,345 ((2S,3S)-cis-2-(diphenylmethyl)-N-((2-methoxyphenyl)- methyl)-1-azabicyclo[2.2.2]octan-3-amine dihydrochloride), a non-peptide antagonist of substance P, the compound was tested against substance P-induced effects on blood pressure in rabbits and on respiration pressure in guinea-pigs. In addition, CP-96,345, and its inactive (2R,3R)-enantiomer, CP-96,344, were also tested in 2 models involving presumably substance P-mediated reflexes in the rat. The fall in blood pressure evoked by i.v. injections of substance P in the rabbit was inhibited by 0.3 mumol kg-1 CP-96,345 i.v. for at least 30 min, and almost abolished, for at least 2 h, by 3 mumol kg-1. In guinea-pigs, the bronchoconstriction induced by i.v. injections of substance P, but not that in response to histamine or bradykinin, was inhibited by CP-96,345 (0.6 and 6.0 mumol kg-1, i.v.) in a dose-dependent manner and this inhibition lasted for 40 min and 70 min, respectively. CP-96,345 (3-20 mumol kg-1, i.v.) reduced depressor reflexes in response to stimulation of peripheral capsaicin-sensitive neurones in the rat. However, the inhibition was not dose-dependent and was also seen with the inactive enantiomer, CP-96,344. This effect can hardly be attributed to receptor-specific effects of CP-96,345 and may be related to unspecific actions such as those involved in the cardiac depression exhibited by both enantiomers. The present results show that CP-96,345 is a potent antagonist of substance P in vivo.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1383835     DOI: 10.1007/bf00173546

Source DB:  PubMed          Journal:  Naunyn Schmiedebergs Arch Pharmacol        ISSN: 0028-1298            Impact factor:   3.000


  20 in total

1.  CP-96,345, a non-peptide antagonist of substance P. III. Cardiovascular effects in mammals unrelated to actions on substance P receptors.

Authors:  J Donnerer; U Stark; H A Tritthart; F Lembeck
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1992-09       Impact factor: 3.000

2.  Investigation into species variants in tachykinin NK1 receptors by use of the non-peptide antagonist, CP-96,345.

Authors:  I J Beresford; P J Birch; R M Hagan; S J Ireland
Journal:  Br J Pharmacol       Date:  1991-10       Impact factor: 8.739

3.  Novel substance P antagonist, CP-96,345, blocks responses of cat spinal dorsal horn neurons to noxious cutaneous stimulation and to substance P.

Authors:  V Radhakrishnan; J L Henry
Journal:  Neurosci Lett       Date:  1991-10-28       Impact factor: 3.046

4.  An unidentified depressor substance in certain tissue extracts.

Authors:  U S V Euler; J H Gaddum
Journal:  J Physiol       Date:  1931-06-06       Impact factor: 5.182

5.  Species differences in affinities of non-peptide antagonists for substance P receptors.

Authors:  B D Gitter; D C Waters; R F Bruns; N R Mason; J A Nixon; J J Howbert
Journal:  Eur J Pharmacol       Date:  1991-05-17       Impact factor: 4.432

6.  Facilitation of the tail-flick reflex by noxious cutaneous stimulation in the rat: antagonism by a substance P analogue.

Authors:  R A Cridland; J L Henry
Journal:  Brain Res       Date:  1988-10-11       Impact factor: 3.252

7.  Pharmacological properties of a C-fibre response evoked by saphenous nerve stimulation in an isolated spinal cord-nerve preparation of the newborn rat.

Authors:  J C Nussbaumer; M Yanagisawa; M Otsuka
Journal:  Br J Pharmacol       Date:  1989-10       Impact factor: 8.739

8.  The role of substance P as a neurotransmitter in the reflexes of slow time courses in the neonatal rat spinal cord.

Authors:  H Akagi; S Konishi; M Otsuka; M Yanagisawa
Journal:  Br J Pharmacol       Date:  1985-03       Impact factor: 8.739

9.  Tachykinin antagonists have potent local anaesthetic actions.

Authors:  C Post; J F Butterworth; G R Strichartz; J A Karlsson; C G Persson
Journal:  Eur J Pharmacol       Date:  1985-11-19       Impact factor: 4.432

10.  Reflex fall in blood pressure mediated by capsaicin-sensitive afferent fibers of the rat splanchnic nerve.

Authors:  F Lembeck; J Donnerer
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1983-05       Impact factor: 3.000

View more
  7 in total

1.  CP-96,345, a non-peptide antagonist of substance P: I. Effects on the actions mediated by substance P and related tachykinins on the guinea-pig ileum and rabbit jejunum.

Authors:  F J Legat; T Griesbacher; F Lembeck
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1992-09       Impact factor: 3.000

2.  CP-96,345, a non-peptide antagonist of substance P. III. Cardiovascular effects in mammals unrelated to actions on substance P receptors.

Authors:  J Donnerer; U Stark; H A Tritthart; F Lembeck
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1992-09       Impact factor: 3.000

3.  Tachykinin-1 receptor antagonism suppresses substance-P- and compound 48/80-induced mast cell activation from rat mast cells expressing functional mas-related GPCR B3.

Authors:  Muhammad N A Sahid; Shuang Liu; Masaki Mogi; Kazutaka Maeyama
Journal:  Inflamm Res       Date:  2020-01-28       Impact factor: 4.575

4.  Effects of the tachykinin NK1 receptor antagonist, RP 67580, on central cardiovascular and behavioural effects of substance P, neurokinin A and neurokinin B.

Authors:  J Culman; B Wiegand; H Spitznagel; S Klee; T Unger
Journal:  Br J Pharmacol       Date:  1995-03       Impact factor: 8.739

5.  Evidence for the participation of glutamate in reflexes involving afferent, substance P-containing nerve fibres in the rat.

Authors:  I Juránek; F Lembeck
Journal:  Br J Pharmacol       Date:  1996-01       Impact factor: 8.739

6.  The interaction of the NK1 receptor antagonist CP-96,345 with L-type calcium channels and its functional consequences.

Authors:  S Guard; S J Boyle; K W Tang; K J Watling; A T McKnight; G N Woodruff
Journal:  Br J Pharmacol       Date:  1993-09       Impact factor: 8.739

7.  Mediation by bradykinin of rat paw oedema induced by collagenase from Clostridium histolyticum.

Authors:  F J Legat; T Griesbacher; F Lembeck
Journal:  Br J Pharmacol       Date:  1994-06       Impact factor: 8.739

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.